Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolic Abnormalities, Telmisartan and HIV Infection

NCT01088295 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT01088295
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01088295 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolic Abnormalities, Telmisartan and HIV Infection
Lead sponsor
University of California, Los Angeles
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2010
Completion date
June 30, 2011
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection